PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
An award-winning grooming brand for men offering natural male beauty products, with the aim of becoming a global market leader. Hawkins & Brimble's range consists of 19 products sold in major retailers such as Sainsbury's, Boots and Etos, as well as in 10 countries around the world.
In the year-to-date, the business has achieved revenues of more than £1.3m and has seen a YoY sales increase of over 100%. The 2018 Lloyds Bank National Business Awards has shortlisted the CEO of Hawkins & Brimble, Stephen Shortt, for The Duke of York New Entrepreneur of the Year Award. The brand has been featured in numerous publications including GQ, The Guardian and Shortlist Magazine.
Hawkins & Brimble is currently sold in Norway, The Netherlands, China, South Africa and many other countries. The brand has registered its trademark in the EU, USA, and China. The company has recently signed a contract to sell their products in India and are currently in discussions with Brazil and Germany to launch their range in 2018/19.
days to go:
Expired
investment:
£136,520
Brew Monster is a Cwmbran-based microbrewery and also the winner of Beverage Industry Award in the Cardiff Regional Awards 2018. It serves primarily the South Wales region, including Cardiff, Newport and Swansea, and is increasingly gaining nation-wide popularity. In just 16 months since its establishment in 2017, Brew Monster has garnered a quarterly turnover of approximately £70,000 (Oct-Dec 2018). In this short period of time, the brewery has also doubled their production capacity, established a profitable micropub and set up a brewery tap.
days to go:
Expired
investment:
£99,250
Urban is a wellness app that allows customers to book massages, beauty treatments, personal training and more at the customer's doorstep in 60 minutes. The company's practitioners are already operating in London, Paris, Manchester and Birmingham covering all aspects of wellness, from massage to mindfulness and beyond. Urban has delivered over 650,000 appointments till date, witnessed £43 million in cumulative sales value since August 2018, onboarded 3,800 partner practitioners, and saw 7,300+ reviews on Apple app store with an average rating of 4.8/5 stars. It will use the investment to drive towards Operating Expense (OpEx) profitability by the end of Q1 2021, reach EBITDA positive by the end of 2021, and scale into new markets through remote expansion.
days to go:
Expired
investment:
£5,877,517
Njori is a company that has created an accurate, multi-functional cooker that can be stored on a bookshelf alongside cookbooks. The cooker uses integrated sensors and accessories to monitor and regulate the cooking process. It's built-in scales helps a user measure ingredients before and during the cooking process. The scale function also enables the user to reduce food by a set weight or percentage. The company aims to be a disruptor in the global portable induction cooker market that is set to be worth £4.5 billion by 2022. Njori has filed UK patents & is building its supply chain in China. It will use the investment to finish development and bring the final product to market.
days to go:
Expired
investment:
£236,797
Hansine is a luxury resort wear brand designed with strong ethical values and produced in London to the booming global market sector. The product's initial launch has proved its global demand with retailers like Liberty and Neiman Marcus. Hansine aims at becoming a definitive luxury destination wear brand. This brand has been worn by the topmost global influencers, and it has been featured by high-profile media platforms such as FT, Elle, Grazia, and The Telegraph. With the proceeds, the company will invest in production, facilitate the third phase of the business plan, staffing and marketing.
days to go:
Expired
investment:
£56,820
